Polyvinyl pyrrolidone–coated silver NPs |
20–50 nm |
0.427, 0.407, and 0.013 mg/kg |
Rats |
NPs are causing impairing of cognition in the offspring. |
Wu et al. (2015)
|
Gold NPs |
10 |
2.85 × 1010 NPs/ml |
In vitro
|
NPs are found to be affecting steroidogenetic capacities by the granulosa cells in culture media after trespassing through the granulosa cell membranes. |
Lyngdoh et al. (2020)
|
Silver nanoparticles |
14 nm |
50 nM |
Mice |
Inner cellular mass was subjected to the induced apoptosis, and embryonic growth shows trophectoderm. |
Li et al. (2010)
|
Gold NPs |
13 |
0.9–7.2 μg/g body weight |
Mice |
NPs get accumulated in the placental and fetal tissues. |
Yang et al. (2018); Bongaerts et al. (2020)
|
Silver nanoparticles |
35 nm |
1.69–2.21 mg/kg |
Rats |
NPs show appearance in the fetal growth. |
Melnik et al. (2013)
|
Gold NPs |
20 |
1 nm for 48 or 72 h |
In-vitro
|
NPs cause the alteration of almost 19 genetic makeups in the fibroblast cells of the lungs of the fetus. |
Gedda et al. (2019)
|
Silver nanoparticles |
8 nm |
250 mg/kg |
Rats |
Pups’ tissues exhibit NP accumulation. |
Lee et al. (2012)
|
Gold NPs |
20 & 50 |
0.01% |
Mice |
NPs can travel through the placenta through endocytic vesicular transportation |
Rattanapinyopituk et al. (2014)
|
Silver nanoparticles |
– |
0.001–100 μg/ml |
In vitro
|
NPs show interference in the reproductive tissue function and alter levels of E2 and P4. |
Scsukova et al. (2013)
|
Gold NPs |
3, 13 & 32 nm |
0.9 μg/g body weight |
Mice |
NPs are found to be enhancing the inflammation of uterine tissues and get accumulated in fetal tissues |
Tian et al. (2013)
|
Silver nanoparticles |
– |
0.09–1.0 mg/ml |
In vitro
|
Intervention by NPs in proliferative pathways and cause apoptotic implications in granulosa cell lines of pork ovaries |
Kolesarova et al. (2011)
|
Gold, silver, and gold-silver alloy |
6 and 20 nm |
0.66 g/L for alloy, 2.5 g/L for silver, and 0.5 g/L for gold |
Pigs’ in vitro ovaries |
NPs are found to be inhibiting the maturation of oocytes, and toxic impacts are increased by the NPs of alloys. |
Tiedemann et al. (2014)
|
Silver nanoparticles |
35 nm |
1.69–2.21 mg/kg |
Mice |
NPs travel in the mother’s breast milk and get accumulated in the developing embryos |
Melnik et al. (2013)
|
Titanium dioxide NPs |
5.5 nm |
10 mg/kg |
Mice |
Initiation of premature oogenesis and causing the apoptotic cell death in ovarian cells, enhancing the atresia in primary and secondary follicular developmental stages |
Zhao et al. (2013)
|
Silver nanoparticles |
55 nm |
0.2–20 mg/kg |
Rats |
Nanoparticle demons |
Charehsaz et al. (2016)
|
Titanium dioxide NPs |
25 nm |
-- |
In vitro
|
Deformation of follicular growth and inhibition of the maturation of oocytes |
Hou and Zhu, (2017)
|
Silver nitrate NPs |
55 nm |
20 mg/kg |
Rats |
NPs damage neurons in the hippocampal regions of the brains of both adults and offspring. |
Charehsaz et al. (2016)
|
Titanium dioxide NPs |
13–27 nm |
1–5 μg/ml |
Chinese hamster ovary cell line |
Genotoxic and cytotoxic outcomes |
Kazimirova et al. (2020)
|
Cadmium oxide NPs |
11–15 nm |
100 or 230 µg |
Mice |
Placental toxic reactions |
Blum et al. (2012)
|
Silver or silver nitrate NPs |
10 nm |
66 mg/kg |
Mice |
NPs caused hampering of the growth of embryos |
Austin et al. (2016)
|
Titanium dioxide NPs |
-- |
2.5, 5, and 10 mg/kg body weight |
Mice |
Alteration in the expressions of relevant ovarian genes in a concentration-dependent manner |
Zhao et al. (2013)
|
Titanium dioxide NPs |
-- |
0.001–100 μg/ml |
In vitro
|
Alteration in the levels of P4 and E2 and interference in reproductive system functions |
Karimipour et al. (2018)
|
Titanium dioxide NPs |
50 nm |
1 μg/ml |
Mice |
NPs crossed the placental barrier and hampered the central nervous system development in the fetus |
Shimizu et al. (2009); Umezawa et al. (2012)
|
Titanium dioxide NPs |
10 nm |
100 mg/kg body weight |
Rats |
NPs exerted neurotoxicity in the brains of neonates and adults |
Mohammadipour et al. (2014), Mohammadipour et al. (2016); Ebrahimzadeh Bideskan et al. (2017)
|
Titanium dioxide NPs |
∼100 nm |
100 mg/kg body weight |
Rats |
Induction of apoptotic phenomena and reduction in neurogenesis |
Mohammadipour et al. (2014), Mohammadipour et al. (2016); Ebrahimzadeh Bideskan et al. (2017)
|
Titanium dioxide NPs |
35 nm |
0.8 mg per animal |
Mice |
Accumulation of NPs in the brain, placental trophoblasts, and liver of the fetus |
Yamashita et al. (2011)
|
Titanium dioxide NPs |
4 nm |
88–108 m2/gm |
Ex-vivo
|
Placental toxicities |
Blum et al. (2012)
|
Aluminum oxide NPs |
9–47 nm |
1–25 μg/ml |
Chinese hamster ovary cell line |
Cytotoxic and genotoxic effects |
Di Virgilio et al. (2010)
|
Cerium oxide NPs |
35 nm |
100 µm |
Mice |
Adverse reactions on oocytes |
Courbiere et al. (2013)
|
Cerium oxide NPs |
35 nm |
10 & 100 µm |
Mice |
NPs got aggregated and accumulated in follicular cells by the endocytotic mechanism and showed distribution in zona pellucida of oocyte cells |
Preaubert et al. (2016)
|
Zinc oxide NPs |
∼100 nm |
500 mg/kg |
Rats |
Reduction in the numbers of live-born pups and enhancement of fetal repsorptive phenomena |
Jo et al. (2013)
|
Zinc oxide NPs |
∼20 nm |
50 or 100 mg/kg |
Hens |
Inflammatory responses, ROS production, and disturbances in the signaling pathway |
Liu et al. (2016)
|
Polyethylene imine and PAA-coated iron oxide NPs |
28–30 nm |
50 mg/kg body weight |
Mice |
NPs lead to the death of the fetus. |
Di Bona et al. (2014)
|
Alpha-iron oxide NPs |
50 & 70 nm |
100 μg/ml |
In vitro
|
Oxidative stress and cellular death |
Faust et al. (2014)
|
Cadmium oxide NPs |
11–15 nm |
100 and 230 mg/m3
|
Mice |
NPs show accumulation in placental tissues and an increase in the weight of the fetus. |
Liu et al. (2017)
|
Silver NPs |
5–70 nm |
0.2 & 2 mg/kg |
Mice |
NPs caused neurobehavioral impairments in the offspring. |
Ghaderi et al. (2015)
|
Copper oxide NPs |
4 nm |
40–44 m2/g |
Ex vivo
|
Reduced cell viabilities and reduction in levels of human chorionic gonadotropins |
Blum et al. (2012)
|